According to Spectrum Pharmaceuticals 's latest financial reports the company's total assets are $0.10 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.10 B | -7.36% |
2021-12-31 | $0.11 B | -43.32% |
2020-12-31 | $0.19 B | -25.29% |
2019-12-31 | $0.26 B | -32.61% |
2018-12-31 | $0.39 B | -19.81% |
2017-12-31 | $0.48 B | 13.68% |
2016-12-31 | $0.42 B | 1.79% |
2015-12-31 | $0.42 B | -14.04% |
2014-12-31 | $0.49 B | -1.83% |
2013-12-31 | $0.49 B | -1.41% |
2012-12-31 | $0.50 B | 80.31% |
2011-12-31 | $0.28 B | 71.59% |
2010-12-31 | $0.16 B | -5.49% |
2009-12-31 | $0.17 B | 38.8% |
2008-12-31 | $0.12 B | 116.78% |
2007-12-31 | $57.54 M | 8.33% |
2006-12-31 | $53.11 M | -18.38% |
2005-12-31 | $65.07 M | 59.66% |
2004-12-31 | $40.75 M | 48.81% |
2003-12-31 | $27.38 M | 693.17% |
2002-12-31 | $3.45 M | -73.07% |
2001-12-31 | $12.82 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 155,514.58% | ๐บ๐ธ USA |
Novartis NVS | $99.94 B | 92,720.99% | ๐จ๐ญ Switzerland |
Pfizer PFE | $226.50 B | 210,256.16% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $73.21 B | 67,895.36% | ๐บ๐ธ USA |
Biogen BIIB | $26.84 B | 24,831.32% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $95.15 B | 88,276.13% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $75.11 B | 69,659.37% | ๐ฌ๐ง UK |
Seagen
SGEN | $3.63 B | 3,275.21% | ๐บ๐ธ USA |
Curis CRIS | $77.28 M | -28.23% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $43.47 B | 40,279.85% | ๐ฎ๐ฑ Israel |